NCT02280590View on ClinicalTrials.gov

Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2015

Conditions
Hyperlipidemia
Interventions
DRUG

Rosuvastatin(Cresnon®)

10mg

DRUG

Rosuvastatin(Crestor®)

10mg

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02280590 - Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia | Biotech Hunter | Biotech Hunter